172 related articles for article (PubMed ID: 36629908)
1. TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytes.
Eckfeld C; Schoeps B; Häußler D; Frädrich J; Bayerl F; Böttcher JP; Knolle P; Heisz S; Prokopchuk O; Hauner H; Munkhbaatar E; Demir IE; Hermann CD; Krüger A
J Cell Biol; 2023 Feb; 222(2):. PubMed ID: 36629908
[TBL] [Abstract][Full Text] [Related]
2. Identification of invariant chain CD74 as a functional receptor of tissue inhibitor of metalloproteinases-1 (TIMP-1).
Schoeps B; Eckfeld C; Flüter L; Keppler S; Mishra R; Knolle P; Bayerl F; Böttcher J; Hermann CD; Häußler D; Krüger A
J Biol Chem; 2021 Sep; 297(3):101072. PubMed ID: 34391782
[TBL] [Abstract][Full Text] [Related]
3. The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis.
Hoe HS; Cooper MJ; Burns MP; Lewis PA; van der Brug M; Chakraborty G; Cartagena CM; Pak DT; Cookson MR; Rebeck GW
J Neurosci; 2007 Oct; 27(40):10895-905. PubMed ID: 17913923
[TBL] [Abstract][Full Text] [Related]
4. Natural haemozoin induces expression and release of human monocyte tissue inhibitor of metalloproteinase-1.
Polimeni M; Valente E; Ulliers D; Opdenakker G; Van den Steen PE; Giribaldi G; Prato M
PLoS One; 2013; 8(8):e71468. PubMed ID: 23967215
[TBL] [Abstract][Full Text] [Related]
5. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells.
Peters HL; Tuli A; Wang X; Liu C; Pan Z; Ouellette MM; Hollingsworth MA; Macdonald RG; Solheim JC
Int J Oncol; 2012 Oct; 41(4):1464-74. PubMed ID: 22797723
[TBL] [Abstract][Full Text] [Related]
6. Tissue Inhibitor of Metalloproteinases-1 Interacts with CD74 to Promote AKT Signaling, Monocyte Recruitment Responses, and Vascular Smooth Muscle Cell Proliferation.
Ebert S; Zang L; Ismail N; Otabil M; Fröhlich A; Egea V; Ács S; Hoeberg M; Berres ML; Weber C; Moreira JMA; Ries C; Bernhagen J; El Bounkari O
Cells; 2023 Jul; 12(14):. PubMed ID: 37508563
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion.
Di Gregoli K; George SJ; Jackson CL; Newby AC; Johnson JL
Cardiovasc Res; 2016 Feb; 109(2):318-30. PubMed ID: 26645981
[TBL] [Abstract][Full Text] [Related]
8. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
Amour A; Knight CG; Webster A; Slocombe PM; Stephens PE; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 2000 May; 473(3):275-9. PubMed ID: 10818225
[TBL] [Abstract][Full Text] [Related]
9. Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy.
Sampson M; Wall S; Baugh M; Worley J; Davies I; Hughes D; Gavrilovic J
Diabetes Res Clin Pract; 2006 Jan; 71(1):45-51. PubMed ID: 16023759
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
Raeeszadeh-Sarmazdeh M; Greene KA; Sankaran B; Downey GP; Radisky DC; Radisky ES
J Biol Chem; 2019 Jun; 294(24):9476-9488. PubMed ID: 31040180
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of TNF-related apoptosis-inducing ligand (TRAIL) elevates levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and prevents type 1 diabetes in nonobese diabetic mice.
Kang S; Park EJ; Joe Y; Seo E; Park MK; Seo SY; Chung HY; Yoo YH; Kim DK; Lee HJ
Endocrinology; 2010 Dec; 151(12):5638-46. PubMed ID: 21047948
[TBL] [Abstract][Full Text] [Related]
12. Effect of focal mild hypothermia on expression of MMP-9, TIMP-1, Tau-1 and β-APP in rats with cerebral ischaemia/reperfusion injury.
Zhao JK; Guan FL; Duan SR; Zhao JW; Sun RH; Zhang LM; Wang DS
Brain Inj; 2013; 27(10):1190-8. PubMed ID: 23895636
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.
Burger D; Rezzonico R; Li JM; Modoux C; Pierce RA; Welgus HG; Dayer JM
Arthritis Rheum; 1998 Oct; 41(10):1748-59. PubMed ID: 9778216
[TBL] [Abstract][Full Text] [Related]
14. Cut loose TIMP-1: an emerging cytokine in inflammation.
Schoeps B; Frädrich J; Krüger A
Trends Cell Biol; 2023 May; 33(5):413-426. PubMed ID: 36163148
[TBL] [Abstract][Full Text] [Related]
15. Oxygen-Loaded Nanodroplets Effectively Abrogate Hypoxia Dysregulating Effects on Secretion of MMP-9 and TIMP-1 by Human Monocytes.
Gulino GR; Magnetto C; Khadjavi A; Panariti A; Rivolta I; Soster M; Argenziano M; Cavalli R; Giribaldi G; Guiot C; Prato M
Mediators Inflamm; 2015; 2015():964838. PubMed ID: 25878404
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10.
Schelter F; Grandl M; Seubert B; Schaten S; Hauser S; Gerg M; Boccaccio C; Comoglio P; Krüger A
Clin Exp Metastasis; 2011 Dec; 28(8):793-802. PubMed ID: 21789719
[TBL] [Abstract][Full Text] [Related]
17. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
18. TIMP-1 and CD82, a promising combined evaluation marker for PDAC.
Zhang J; Wu T; Zhan S; Qiao N; Zhang X; Zhu Y; Yang N; Sun Y; Zhang XA; Bleich D; Han X
Oncotarget; 2017 Jan; 8(4):6496-6512. PubMed ID: 28030805
[TBL] [Abstract][Full Text] [Related]
19. APLP1 and APLP2, members of the APP family of proteins, behave similarly to APP in that they associate with NMDA receptors and enhance NMDA receptor surface expression.
Cousins SL; Dai W; Stephenson FA
J Neurochem; 2015 Jun; 133(6):879-85. PubMed ID: 25683482
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines.
Spitzer P; Walter M; Göth C; Oberstein TJ; Linning P; Knölker HJ; Kornhuber J; Maler JM
Front Immunol; 2020; 11():1967. PubMed ID: 33013850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
